Top events
Valorant
Marvel Rivals
Deadlock
2025-06-14 14:46:23
2025-06-15 14:46:23
2025-06-16 14:46:23
2025-06-17 14:46:23
Scores
Valorant Marvel Rivals Deadlock Counter-Strike 2 Soon
2022-06-07 17:00:01
0 - 1
Best of 1
Finished
Map 1 Icebox
10 5 / 5
52:07 Duration
win
13 6 / 7
1 2 3 4 5 6 7 8 9 10 11 12
13 14 15 16 17 18 19 20 21 22 23 24
UCAM EC
Heretic
1 2 3 4 5 6 7 8 9 10 11 12
UCAM EC
Heretic
13 14 15 16 17 18 19 20 21 22 23 24
UCAM EC
Heretic
Overview
Advanced
Kills
Player
kda
+/-
KAST
ACS
ADR
Rating 3.0
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
Show advanced stats
24 / 16 / 6
+8
61.00%
256.00
162.00
1.16
33%
55
1
2
-1
-
-
-
18 / 17 / 5
+1
78.00%
220.00
153.00
1.09
28%
205
4
2
+2
-
-
-
15 / 16 / 9
-1
83.00%
218.00
150.00
0.97
21%
3
-
1
-1
-
-
-
12 / 18 / 12
-6
70.00%
168.00
117.00
0.78
30%
50
1
-
+1
-
-
-
12 / 21 / 3
-9
57.00%
163.00
108.00
0.73
30%
268
5
7
-2
-
-
-
Player
kda
+/-
ADR
Rating 3.0
ACS
KAST
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
24 / 16 / 6
+8
162.00
1.16
256.00
61.00%
33%
55
1
2
-1
-
-
-
18 / 17 / 5
+1
153.00
1.09
220.00
78.00%
28%
205
4
2
+2
-
-
-
15 / 16 / 9
-1
150.00
0.97
218.00
83.00%
21%
3
-
1
-1
-
-
-
12 / 18 / 12
-6
117.00
0.78
168.00
70.00%
30%
50
1
-
+1
-
-
-
12 / 21 / 3
-9
108.00
0.73
163.00
57.00%
30%
268
5
7
-2
-
-
-
Player
kda
+/-
KAST
ACS
ADR
Rating 3.0
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
Show advanced stats
21 / 15 / 2
+6
65.00%
250.00
161.00
1.12
35%
110
2
4
-2
-
-
-
19 / 16 / 2
+3
83.00%
225.00
130.00
1.11
27%
258
5
3
+2
-
-
-
20 / 18 / 8
+2
74.00%
255.00
174.00
1.06
28%
105
2
2
0
-
-
-
18 / 19 / 8
-1
70.00%
233.00
158.00
0.92
31%
55
1
2
-1
-
-
-
10 / 13 / 8
-3
78.00%
139.00
113.00
0.83
20%
100
2
-
+2
-
-
-
Player
kda
+/-
ADR
Rating 3.0
ACS
KAST
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
21 / 15 / 2
+6
161.00
1.12
250.00
65.00%
35%
110
2
4
-2
-
-
-
19 / 16 / 2
+3
130.00
1.11
225.00
83.00%
27%
258
5
3
+2
-
-
-
20 / 18 / 8
+2
174.00
1.06
255.00
74.00%
28%
105
2
2
0
-
-
-
18 / 19 / 8
-1
158.00
0.92
233.00
70.00%
31%
55
1
2
-1
-
-
-
10 / 13 / 8
-3
113.00
0.83
139.00
78.00%
20%
100
2
-
+2
-
-
-